$17.44
-0.34-1.91%
At close: -
$17.17
-0.27-1.55%
After Hours: 4:14 PM EDT
Comments
Loading...
Latest Apellis Pharmaceuticals Stock News | NASDAQ:APLS | Benzinga
Get the latest news on Apellis Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Apellis Pharmaceuticals performance
Categories: All
Thursday, May 22, 2025
Wednesday, May 14, 2025
Friday, May 09, 2025
Thursday, May 08, 2025
Wednesday, May 07, 2025
- Needham Maintains Buy on Apellis Pharmaceutic...
- Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Apellis Pharmaceuticals shares are trading lo...
- Apellis Pharmaceuticals' Cash And Cash Equiva...
- Apellis Pharmaceuticals Q1 EPS $(0.74) May No...
- Earnings Scheduled For May 7, 2025
Tuesday, May 06, 2025
Tuesday, April 29, 2025
Monday, April 21, 2025
Wednesday, April 02, 2025
Tuesday, April 01, 2025
Tuesday, March 18, 2025
Wednesday, March 05, 2025
Tuesday, March 04, 2025
Monday, March 03, 2025
Friday, February 28, 2025
Thursday, February 20, 2025
Thursday, February 13, 2025
Wednesday, January 29, 2025
Monday, January 27, 2025
Tuesday, January 21, 2025
Tuesday, January 14, 2025
Monday, January 13, 2025
Tuesday, December 17, 2024
- Apellis Pharmaceuticals shares are trading lo...
- Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
- Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (20 Ratings)
- Goldman Sachs Downgrades Apellis Pharmaceutic...
